Updated daily
Drug recalls
Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.
Class IITerminatedMar 11, 2020BETAMETHASONE ACETATE/BETAMETHASONELack of Assurance of SterilityFusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical · D-0942-2020Class IITerminatedMar 11, 2020B-COMPLEX 110 INJECTABLELack of Assurance of SterilityFusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical · D-0941-2020Class IITerminatedMar 11, 2020AscorbiXLack of Assurance of SterilityFusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical · D-0940-2020Class IITerminatedMar 11, 2020AscorbiXLack of Assurance of SterilityFusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical · D-0939-2020Class IITerminatedMar 11, 2020Alprostadil/Papaverine Hydrochloride/Phentolamine Mesylate Injection 40MCG/30MG/2MG/ML InjectableLack of Assurance of SterilityFusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical · D-0938-2020Class IITerminatedMar 11, 2020Alprostadil/Papaverine Hydrochloride/Phentolamine Mesylate Injection 20MCG/30MG/1MG/ML InjectableLack of Assurance of SterilityFusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical · D-0937-2020Class IITerminatedMar 11, 2020AlprostadilLack of Assurance of SterilityFusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical · D-0936-2020Class IITerminatedMar 11, 2020AlprostadilLack of Assurance of SterilityFusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical · D-0935-2020Class IITerminatedMar 11, 2020Alprostadil/Papaverine Hydrochloride/Phentolamine Mesylate/Atropine Sulfate InjectionLack of Assurance of SterilityFusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical · D-0934-2020Class IITerminatedMar 11, 2020Alprostadil/Papaverine Hydrochloride/Phentolamine Mesylate/Atropine Sulfate InjectionLack of Assurance of SterilityFusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical · D-0933-2020Class IITerminatedMar 11, 2020Alprostadil/Papaverine Hydrochloride/Phentolamine Mesylate/Atropine Sulfate InjectionLack of Assurance of SterilityFusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical · D-0932-2020Class IIITerminatedMar 11, 2020Discount Drug MartLabeling: Incorrect or Missing Lot and/or Expiration date.AAA Pharmaceutical, Inc. · D-0868-2020Class IITerminatedMar 11, 2020Desoximetasone Topical SprayFailed Impurities/Degradation Specification; high out of specification results observedLupin Pharmaceuticals Inc. · D-0866-2020Class IITerminatedMar 11, 2020Mesalamine Delayed-Release TabletsFailed Dissolution Specifications: Low out of specification dissolution result observed during stability testing.Teva Pharmaceuticals USA · D-0862-2020Class IIITerminatedMar 4, 2020Zoledronic Acid Injection 5 mg/100 mLFailed Impurities/Degradation Specifications: Out-of-specification results obtained for impurities during stability testing.Breckenridge Pharmaceutical, Inc · D-1063-2020Class ITerminatedMar 4, 2020Phenytoin Oral Suspension USPResuspension Problems: Two lots of Phenytoin Oral Suspension USP 125mg/5mL may coagulate and may not resuspend as per the label copy instructions.Taro Pharmaceuticals U.S.A., Inc. · D-0863-2020Class IIITerminatedMar 4, 2020CVS Health Sodium Chloride Ophthalmic Ointment USPPresence of Particulate Matter: Brown spots observed on the inside of the tube of product, identified as tin with trace copper, which are the base of the materials of...Akorn, Inc. · D-0861-2020Class IIITerminatedMar 4, 2020Well at Walgreens Sodium Chloride Ophthalmic Ointment USPPresence of Particulate Matter: Brown spots observed on the inside of the tube of product, identified as tin with trace copper, which are the base of the materials of...Akorn, Inc. · D-0860-2020Class IIITerminatedMar 4, 2020Sodium Chloride Ophthalmic Ointment USPPresence of Particulate Matter: Brown spots observed on the inside of the tube of product, identified as tin with trace copper, which are the base of the materials of...Akorn, Inc. · D-0859-2020Class IIITerminatedMar 4, 2020TRAMADOL HYDROCHLORIDE TabletsLabeling: Incorrect package insert - Patient leaflets for the specified lots of unscored tablets contain language relative to a 25 mg dosing titration that necessitates...Golden State Medical Supply Inc. · D-0856-2020Class IIITerminatedFeb 26, 2020Glycopyrrolate InjectionFailed Impurities/Degradation Specifications: elevated levels of Benzaldehyde impurity was found in investigative samples (retain samples).AuroMedics Pharma LLC · D-0853-2020Class IIITerminatedFeb 26, 2020Tramadol Hydrochloride Tablets USP CIVLabeling: Incorrect package insert - Patient leaflets for the specified lots of unscored tablets contain language relative to a 25 mg dosing titration that necessitates...Teva Pharmaceuticals USA · D-0851-2020Class IITerminatedFeb 26, 2020Glycopyrrolate TabsFailed Impurities/Degradation Specification: High Out of Specification Results for Individual Unknown Impurity.NCS Healthcare of Kentucky Inc · D-0850-2020Class IITerminatedFeb 26, 2020Desmopressin Acetate TabletsGMP Deviations: Product bottle may be absent of desiccant.American Health Packaging · D-0849-2020Class IITerminatedFeb 26, 2020Desmopressin Acetate TabletsGMP Deviations: Product bottle may be absent of desiccant.American Health Packaging · D-0848-2020Class IIITerminatedFeb 26, 2020Memantine Hydrochloride Extended-release CapsulesFailed Dissolution Specifications: High out of specification result observed at stability studies.The Harvard Drug Group · D-0844-2020Class IITerminatedFeb 19, 2020Theraflu Cough ReliefLabeling: Label Lacks Warning: Product recalled due to absence of a warning statement on the product label, Ask a doctor before use if you have a sodium-restricted diet.GSK Consumer Health, Inc · D-0996-2020Class ITerminatedFeb 19, 2020Ketorolac TromPresence of Particulate Matter: Medication relabeled at facility was recalled by the manufacturer due to small black particles noticed during routine visual inspection...RemedyRepack Inc. · D-0867-2020Class IITerminatedFeb 19, 2020Major Extra Strength Acetaminophen TabletsPresence of Foreign Tablets/Capsules: Complaint involving one Women's Prenatal dietary supplement tablet commingled in a bottle of Extra Strength Acetaminophen 500 mg...Contract Pharmacal Corporation · D-0858-2020Class IITerminatedFeb 19, 2020Leader Extra Strength Acetaminophen TabletsPresence of Foreign Tablets/Capsules: Complaint involving one Women's Prenatal dietary supplement tablet commingled in a bottle of Extra Strength Acetaminophen 500 mg...Contract Pharmacal Corporation · D-0857-2020Class IITerminatedFeb 19, 2020Memantine Hydrochloride Extended Release CapsulesFailed Dissolution Specifications: Low out of specification results observed in dissolution test at six-month long-term stability study.Lupin Pharmaceuticals Inc. · D-0855-2020Class IITerminatedFeb 19, 2020Raloxifene Hydrochloride TabletsFailed Dissolution Specifications: Low out of specification results obtained during stability testing.American Health Packaging · D-0854-2020Class IITerminatedFeb 19, 2020Amoxicillin and Clavulanate Potassium TabletsPresence of Foreign Substance: Customer complaint of a foreign substance identified as nylon cable tieAuroMedics Pharma LLC · D-0852-2020Class IITerminatedFeb 19, 2020New! Rompe Pecho MAX Multi SymptomsMicrobial Contamination of Non-Sterile ProductsEfficient Laboratories, Inc. · D-0847-2020Class IITerminatedFeb 19, 2020Rompe Pecho EX ExpectorantMicrobial Contamination of Non-Sterile ProductsEfficient Laboratories, Inc. · D-0846-2020Class IITerminatedFeb 19, 2020Rompe Pecho CF Cold & Flu with HoneyMicrobial Contamination of Non-Sterile ProductsEfficient Laboratories, Inc. · D-0845-2020Class IIITerminatedFeb 19, 2020Frovatriptan Succinate TabletsLabeling: Incorrect or Missing Lot and/or Exp Date: Product incorrectly labeled with an expiration date of August 2022 rather than the correct expiration date of April...Par Pharmaceutical Inc. · D-0843-2020Class IITerminatedFeb 19, 2020Caduet (amlodipine besylate/atorvastatin calcium) TabletsDefective Container: products potentially could have been packaged in defective bottles, with a notched rim, that could cause inadequate foil sealing resulting in lack...Pfizer Inc. · D-0842-2020Class IITerminatedFeb 19, 2020Caduet (amlodipine besylate/atorvastatin calcium) TabletsDefective Container: products potentially could have been packaged in defective bottles, with a notched rim, that could cause inadequate foil sealing resulting in lack...Pfizer Inc. · D-0841-2020Class IITerminatedFeb 19, 2020Kushim TabletsMarketed Without an Approved NDA/ANDA. FDA analysis found product to contain cinobufagin, bufalin, and bufotenineB And A Trading Corporation · D-0840-2020